NOT KNOWN DETAILS ABOUT CONOLIDINE

In 2011, the Bohn lab observed antinociception from the two chemically induced and inflammation-derived agony, and experiments indicated deficiency of opioid receptor modulation, but were being struggling to outline a specific goal."We confirmed that conolidine binds for the freshly identified opioid receptor ACKR3, whilst demonstrating no affinity